Document is current

Any future updates will be listed below

Geringeres Rückfallrisiko unter Mycophenolat Mofetil plus Glukokortikoid in der Erstlinie

Crossref DOI link: https://doi.org/10.1007/s15004-021-8886-1

Published Online: 2021-12-14

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark